» Articles » PMID: 32059522

Pathogenic Mitochondria DNA Mutations: Current Detection Tools and Interventions

Overview
Journal Genes (Basel)
Publisher MDPI
Date 2020 Feb 16
PMID 32059522
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Mitochondria are best known for their role in energy production, and they are the only mammalian organelles that contain their own genomes. The mitochondrial genome mutation rate is reported to be 10-17 times higher compared to nuclear genomes as a result of oxidative damage caused by reactive oxygen species during oxidative phosphorylation. Pathogenic mitochondrial DNA mutations result in mitochondrial DNA disorders, which are among the most common inherited human diseases. Interventions of mitochondrial DNA disorders involve either the transfer of viable isolated mitochondria to recipient cells or genetically modifying the mitochondrial genome to improve therapeutic outcome. This review outlines the common mitochondrial DNA disorders and the key advances in the past decade necessary to improve the current knowledge on mitochondrial disease intervention. Although it is now 31 years since the first description of patients with pathogenic mitochondrial DNA was reported, the treatment for mitochondrial disease is often inadequate and mostly palliative. Advancements in diagnostic technology improved the molecular diagnosis of previously unresolved cases, and they provide new insight into the pathogenesis and genetic changes in mitochondrial DNA diseases

Citing Articles

Engineered mitochondria in diseases: mechanisms, strategies, and applications.

Li M, Wu L, Si H, Wu Y, Liu Y, Zeng Y Signal Transduct Target Ther. 2025; 10(1):71.

PMID: 40025039 PMC: 11873319. DOI: 10.1038/s41392-024-02081-y.


Protective effect of afamin protein against oxidative stress related injury in human ovarian granulosa cells.

Zhang Q, Zheng X, Zhang X, Zheng L J Ovarian Res. 2024; 17(1):189.

PMID: 39342320 PMC: 11437624. DOI: 10.1186/s13048-024-01511-3.


Using 8-Hydroxy-2'-Deoxiguanosine (8-OHdG) as a Reliable Biomarker for Assessing Periodontal Disease Associated with Diabetes.

Goriuc A, Cojocaru K, Luchian I, Ursu R, Butnaru O, Foia L Int J Mol Sci. 2024; 25(3).

PMID: 38338704 PMC: 10855048. DOI: 10.3390/ijms25031425.


Sequencing of N-methyl-deoxyadenosine at single-base resolution across the mammalian genome.

Feng X, Cui X, Zhang L, Ye C, Wang P, Zhong Y Mol Cell. 2024; 84(3):596-610.e6.

PMID: 38215754 PMC: 10872247. DOI: 10.1016/j.molcel.2023.12.021.


A Comparative Analysis of Selection Pressures Suffered by Mitochondrial Genomes in Two Planthopper Species with Divergent Climate Distributions.

Sun K, Ding Y, Chen L, Sun J Int J Mol Sci. 2023; 24(23).

PMID: 38069176 PMC: 10706623. DOI: 10.3390/ijms242316847.


References
1.
Gorman G, Schaefer A, Ng Y, Gomez N, Blakely E, Alston C . Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease. Ann Neurol. 2015; 77(5):753-9. PMC: 4737121. DOI: 10.1002/ana.24362. View

2.
Ahn E, Hirohata K, Kohrn B, Fox E, Chang C, Loeb L . Detection of Ultra-Rare Mitochondrial Mutations in Breast Stem Cells by Duplex Sequencing. PLoS One. 2015; 10(8):e0136216. PMC: 4549069. DOI: 10.1371/journal.pone.0136216. View

3.
Lehmann D, Schubert K, Joshi P, Hardy S, Tuppen H, Baty K . Pathogenic mitochondrial mt-tRNA(Ala) variants are uniquely associated with isolated myopathy. Eur J Hum Genet. 2015; 23(12):1735-8. PMC: 4519577. DOI: 10.1038/ejhg.2015.73. View

4.
Wallace D . Mitochondrial defects in neurodegenerative disease. Ment Retard Dev Disabil Res Rev. 2001; 7(3):158-66. DOI: 10.1002/mrdd.1023. View

5.
Ling J, Roy H, Qin D, Rubio M, Alfonzo J, Fredrick K . Pathogenic mechanism of a human mitochondrial tRNAPhe mutation associated with myoclonic epilepsy with ragged red fibers syndrome. Proc Natl Acad Sci U S A. 2007; 104(39):15299-304. PMC: 2000536. DOI: 10.1073/pnas.0704441104. View